Evidence map›Paper›PMID 27296993›Full record

ArticleHypertension (Dallas, Tex. : 1979)2016

Differential Sex Response to Aspirin in Decreasing Aneurysm Rupture in Humans and Mice.

Nohra Chalouhi, Robert M Starke, Tatiana Correa, Pascal M Jabbour, Mario Zanaty, Robert D Brown, James C Torner, David M Hasan

Open access · bronzeAbstract read
In one paragraph

Article in Hypertension (Dallas, Tex. : 1979), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Why Are Women Predisposed to Intracranial Aneurysm?Frontiers in cardiovascular medicine · 2022
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Nohra ChalouhiFrom the Department of Neurological Surgery, Thomas Jefferson University and Jefferson Hospital for Neuroscience, Philadelphia, PA (N.C., P.M.J.); Department of Neurological Surgery, University of Virginia School of Medicine, Charlottesville (R.M.S.); Carver College of Medicine (T.C.), Department of Neurological Surgery (M.Z., D.M.H.), and Department of Epidemiology, College of Public Health (J.C.T.), University of Iowa; and Department of Neurology, Mayo Clinic College of Medicine, Rochester, MN (R.D.B.).
Robert M StarkeFrom the Department of Neurological Surgery, Thomas Jefferson University and Jefferson Hospital for Neuroscience, Philadelphia, PA (N.C., P.M.J.); Department of Neurological Surgery, University of Virginia School of Medicine, Charlottesville (R.M.S.); Carver College of Medicine (T.C.), Department of Neurological Surgery (M.Z., D.M.H.), and Department of Epidemiology, College of Public Health (J.C.T.), University of Iowa; and Department of Neurology, Mayo Clinic College of Medicine, Rochester, MN (R.D.B.).
Tatiana CorreaFrom the Department of Neurological Surgery, Thomas Jefferson University and Jefferson Hospital for Neuroscience, Philadelphia, PA (N.C., P.M.J.); Department of Neurological Surgery, University of Virginia School of Medicine, Charlottesville (R.M.S.); Carver College of Medicine (T.C.), Department of Neurological Surgery (M.Z., D.M.H.), and Department of Epidemiology, College of Public Health (J.C.T.), University of Iowa; and Department of Neurology, Mayo Clinic College of Medicine, Rochester, MN (R.D.B.).
Pascal M JabbourFrom the Department of Neurological Surgery, Thomas Jefferson University and Jefferson Hospital for Neuroscience, Philadelphia, PA (N.C., P.M.J.); Department of Neurological Surgery, University of Virginia School of Medicine, Charlottesville (R.M.S.); Carver College of Medicine (T.C.), Department of Neurological Surgery (M.Z., D.M.H.), and Department of Epidemiology, College of Public Health (J.C.T.), University of Iowa; and Department of Neurology, Mayo Clinic College of Medicine, Rochester, MN (R.D.B.).
Mario ZanatyFrom the Department of Neurological Surgery, Thomas Jefferson University and Jefferson Hospital for Neuroscience, Philadelphia, PA (N.C., P.M.J.); Department of Neurological Surgery, University of Virginia School of Medicine, Charlottesville (R.M.S.); Carver College of Medicine (T.C.), Department of Neurological Surgery (M.Z., D.M.H.), and Department of Epidemiology, College of Public Health (J.C.T.), University of Iowa; and Department of Neurology, Mayo Clinic College of Medicine, Rochester, MN (R.D.B.).
Robert D BrownFrom the Department of Neurological Surgery, Thomas Jefferson University and Jefferson Hospital for Neuroscience, Philadelphia, PA (N.C., P.M.J.); Department of Neurological Surgery, University of Virginia School of Medicine, Charlottesville (R.M.S.); Carver College of Medicine (T.C.), Department of Neurological Surgery (M.Z., D.M.H.), and Department of Epidemiology, College of Public Health (J.C.T.), University of Iowa; and Department of Neurology, Mayo Clinic College of Medicine, Rochester, MN (R.D.B.).
James C TornerFrom the Department of Neurological Surgery, Thomas Jefferson University and Jefferson Hospital for Neuroscience, Philadelphia, PA (N.C., P.M.J.); Department of Neurological Surgery, University of Virginia School of Medicine, Charlottesville (R.M.S.); Carver College of Medicine (T.C.), Department of Neurological Surgery (M.Z., D.M.H.), and Department of Epidemiology, College of Public Health (J.C.T.), University of Iowa; and Department of Neurology, Mayo Clinic College of Medicine, Rochester, MN (R.D.B.).
David M HasanFrom the Department of Neurological Surgery, Thomas Jefferson University and Jefferson Hospital for Neuroscience, Philadelphia, PA (N.C., P.M.J.); Department of Neurological Surgery, University of Virginia School of Medicine, Charlottesville (R.M.S.); Carver College of Medicine (T.C.), Department of Neurological Surgery (M.Z., D.M.H.), and Department of Epidemiology, College of Public Health (J.C.T.), University of Iowa; and Department of Neurology, Mayo Clinic College of Medicine, Rochester, MN (R.D.B.). david-hasan@uiowa.edu.
Neurological Surgery · USUniversity of Virginia · USThomas Jefferson University · US

Funding

Unruptured Intracranial Aneurysms: Neurologic OutcomeR01NS048597 · NINDS · UNIVERSITY OF IOWA · PI TORNER, JAMES C · 2004 to 2007
$1.9M
Mechanisms of Effect of Aspirin on Cerebral Aneurysms in MiceK08NS082363 · NINDS · UNIVERSITY OF IOWA · PI HASAN, DAVID M. · 2013 to 2017
$846k
Aneurysm Sac Growth as the Etiology of Recurrence in Coiled Cerebral AneurysmsR03NS079227 · NINDS · UNIVERSITY OF IOWA · PI HASAN, DAVID M. · 2012 to 2013
$148k
NINDS NIH HHS K08 NS082363NINDS NIH HHS R01 NS048597NINDS NIH HHS R03 NS079227
6 · The paper itself

Abstract

We previously found that aspirin decreases the risk of cerebral aneurysm rupture in humans. We aim to assess whether a sex differential exists in the response of human cerebral aneurysms to aspirin and confirm these observations in a mouse model of cerebral aneurysm. A nested case-control analysis from the International Study of Unruptured Intracranial Aneurysms was performed to assess whether a sex differential exists in the response of human cerebral aneurysms to aspirin. A series of experiments were subsequently performed in a mouse model of cerebral aneurysms. Aneurysms were induced with hypertension and elastase injection into mice basal cisterns. We found that aspirin decreased the risk of aneurysm rupture more significantly in men than in women in the International Study of Unruptured Intracranial Aneurysms. In mice, aspirin and cyclooxygenase-2 inhibitor did not affect cerebral aneurysm formation but significantly decreased the incidence of rupture. The incidence of rupture was significantly lower in male versus female mice on aspirin. Gene expression analysis from cerebral arteries showed higher 15-hydroxyprostaglandin dehydrogenase levels in male mice. The rate of cerebral aneurysm rupture was similar in male mice receiving aspirin and 15-hydroxyprostaglandin dehydrogenase inhibitor compared with females receiving aspirin and 15-hydroxyprostaglandin dehydrogenase agonist, signaling a reversal of the sex-differential response to aspirin. Aspirin decreases aneurysm rupture in human and mice, in part through cyclooxygenase-2 pathways. Evidence from animal and human studies suggests a consistent differential effect by sex. 15-Hydroxyprostaglandin dehydrogenase activation in females reduces the incidence of rupture and eliminates the sex-differential response to aspirin.

Indexed as

AspirinHydroxyprostaglandin DehydrogenasesAneurysm, RupturedAnimalsCerebral ArteriesCyclooxygenase 2Cyclooxygenase InhibitorsDisease Models, AnimalFemaleFollow-Up StudiesHumansIncidenceIntracranial AneurysmMaleMiceRisk Factors15-hydroxyprostaglandin dehydrogenaseAspirinCyclooxygenase 2Cyclooxygenase InhibitorsHydroxyprostaglandin Dehydrogenasesaneurysmaspirininflammationsexsubarachnoid hemorrhage

Identifiers

PMID27296993
PMCPMC4945417
OpenAlexW2430117386

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.